Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use LEVOLEUCOVORIN INJECTION safely and effectively. See full prescribing information for LEVOLEUCOVORIN INJECTION. LEVOLEUCOVORIN injection, solution for intravenous use Initial U.S. Approval: 1952 (d,l-leucovorin), 2008 (levoleucovorin)
Medication labelWhy this: Advisory · dailymed-prescription
Levoleucovorin injection is a folate analog. Levoleucovorin injection rescue is indicated after high-dose methotrexate therapy in osteosarcoma. Levoleucovorin injection is also indicated to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists. Levoleucovorin injection is indicated for use in combination chemotherapy with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer. · Levoleucovorin injection is not approved for pernicious anemia and megaloblastic anemias secondary to the lack of vitamin B12.Improper use may cause a hematologic remission while neurologic manifestations continue to progress.
- generic_name
- levoleucovorin
- product_names
- LEVOLEUCOVORIN
- ndc
- 43598-771, 43598-773, 43598-771-11, 43598-773-11
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en